| Literature DB >> 18819304 |
Umar Sadat1, Caleb Ward, Jonathan H Gillard, Michael Gaunt.
Abstract
Venous thromboembolism is a significant cause of morbidity and mortality worldwide. Anticoagulation is the preferred treatment, but is not feasible in some patients. Caval interruption is the treatment of choice for prevention of recurrent pulmonary embolism. This article looks at the development of caval interruption.Entities:
Mesh：
Year: 2008 PMID： 18819304 DOI： 10.12968/hmed.2008.69.9.31048
Source DB: PubMed Journal: Br J Hosp Med (Lond) ISSN： 1750-8460 Impact factor: 0.825